Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors and Risk of Cardiovascular Events

Clinical trial NCT03939624 · COMPLETED

Trial details

NCT number: NCT03939624
Sponsor: Canadian Network for Observational Drug Effect Studies, CNODES
Status: COMPLETED
Study type: OBSERVATIONAL

Type2 Diabetes Myocardial Infarction Ischemic Stroke Cardiovascular Death Heart Failure All-Cause Mortality

Start date: 2018-10-01
Primary completion: 2019-10-01
Enrollment: 419734

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.